Neurogenic Detrusor Overactivity Ndo clinical trials

Explore recruiting neurogenic detrusor overactivity ndo clinical trials.

Recruiting neurogenic detrusor overactivity ndo studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurogenic Detrusor Overactivity Ndo trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Open Label, Multicenter, Baseline-controlled Sequential Dose Titration Study Followed by a Fixed Dose Observation Period to Evaluate Pharmacokinetics, Efficacy and Safety of Mirabegron Prolonged-release Microgranula-based Suspension in Children from 6 Months to Less Than 3 Years of Age with Neurogenic Detrusor Overactivity

Denmark, Belgium, Poland, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

Lithuania, Croatia, Latvia, Denmark, Romania, Belgium +3 more

Phase II and Phase III (Integrated) EU CTIS Study details

Neurogenic Detrusor Overactivity Ndo trials by city

Neurogenic Detrusor Overactivity Ndo in Toronto Neurogenic Detrusor Overactivity Ndo in Vancouver Neurogenic Detrusor Overactivity Ndo in Montreal Neurogenic Detrusor Overactivity Ndo in Calgary Neurogenic Detrusor Overactivity Ndo in Edmonton Neurogenic Detrusor Overactivity Ndo in Ottawa Neurogenic Detrusor Overactivity Ndo in Winnipeg Neurogenic Detrusor Overactivity Ndo in Quebec City Neurogenic Detrusor Overactivity Ndo in Hamilton Neurogenic Detrusor Overactivity Ndo in Kitchener Neurogenic Detrusor Overactivity Ndo in London Neurogenic Detrusor Overactivity Ndo in Halifax Neurogenic Detrusor Overactivity Ndo in New York Neurogenic Detrusor Overactivity Ndo in Los Angeles Neurogenic Detrusor Overactivity Ndo in Chicago Neurogenic Detrusor Overactivity Ndo in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease